Shanghai MicroPort Endovascular MedTech (SHA:688016) subsidiary Shanghai Lanmai Medical Technology registered its medical device with China's food and drug administrator.
The registration of the peripheral balloon dilatation catheter is valid until Dec. 15, 2029, according to a Thursday filing with the Shanghai bourse.
The catheter is suitable for the peripheral vascular system and for the treatment of obstructive lesions of autologous or artificial arteriovenous dialysis fistulas.
Shares of the device maker were down 1% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments